61 related articles for article (PubMed ID: 30830803)
21. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibalpha inhibit platelet dependent thrombin generation by different mechanisms.
Thomas S; Metcalfe P; Goodall AH; Gray E
Thromb Haemost; 2000 Jul; 84(1):98-103. PubMed ID: 10928478
[TBL] [Abstract][Full Text] [Related]
22. Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.
Weeterings C; Adelmeijer J; Myles T; de Groot PG; Lisman T
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):670-5. PubMed ID: 16357309
[TBL] [Abstract][Full Text] [Related]
23. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions.
Goto S; Ikeda Y; Saldívar E; Ruggeri ZM
J Clin Invest; 1998 Jan; 101(2):479-86. PubMed ID: 9435321
[TBL] [Abstract][Full Text] [Related]
24. New alleles of the platelet glycoprotein Ibalpha gene.
Corral J; González-Conejero R; Lozano ML; Rivera J; Vicente V
Br J Haematol; 1998 Dec; 103(4):997-1003. PubMed ID: 9886311
[TBL] [Abstract][Full Text] [Related]
25. Triflamp, a snake venom metalloproteinase, reduces neutrophil-platelet adhesion through proteolysis of PSGL-1 but not glycoprotein Ib alpha.
Tseng YL; Lee CJ; Hsu CC; Huang TF
Thromb Haemost; 2004 Jun; 91(6):1177-85. PubMed ID: 15175805
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs 10a and 10b Regulate the Expression of Human Platelet Glycoprotein Ibα for Normal Megakaryopoiesis.
Zhang Z; Ran Y; Shaw TS; Peng Y
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834869
[TBL] [Abstract][Full Text] [Related]
27. Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in Sickle Cell Disease.
Jimenez MA; Novelli E; Shaw GD; Sundd P
Blood Adv; 2017 Sep; 1(20):1712-1716. PubMed ID: 28966995
[TBL] [Abstract][Full Text] [Related]
28. Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene.
Salomon O; Rosenberg N; Steinberg DM; Huna-Baron R; Moisseiev J; Dardik R; Goldan O; Kurtz S; Ifrah A; Seligsohn U
Ophthalmology; 2004 Jan; 111(1):184-8. PubMed ID: 14711733
[TBL] [Abstract][Full Text] [Related]
29. Engineering and characterization of a chimeric anti-platelet glycoprotein Ibalpha monoclonal antibody and preparation of its Fab fragment.
Yang J; Ji S; Dong N; Zhao Y; Ruan C
Hybridoma (Larchmt); 2010 Apr; 29(2):125-32. PubMed ID: 20443704
[TBL] [Abstract][Full Text] [Related]
30. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha.
Celikel R; McClintock RA; Roberts JR; Mendolicchio GL; Ware J; Varughese KI; Ruggeri ZM
Science; 2003 Jul; 301(5630):218-21. PubMed ID: 12855810
[TBL] [Abstract][Full Text] [Related]
31. The cytoplasmic domain of glycoprotein (GP) Ibalpha constrains the lateral diffusion of the GP Ib-IX complex and modulates von Willebrand factor binding.
Dong JF; Li CQ; Sae-Tung G; Hyun W; Afshar-Kharghan V; López JA
Biochemistry; 1997 Oct; 36(41):12421-7. PubMed ID: 9376345
[TBL] [Abstract][Full Text] [Related]
32. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
Goto S; Tamura N; Eto K; Ikeda Y; Handa S
Circulation; 2002 May; 105(21):2531-6. PubMed ID: 12034661
[TBL] [Abstract][Full Text] [Related]
33. Hyperthermia induces platelet apoptosis and glycoprotein Ibalpha ectodomain shedding.
Wang Z; Shi Q; Li S; Du J; Liu J; Dai K
Platelets; 2010; 21(3):229-37. PubMed ID: 20158380
[TBL] [Abstract][Full Text] [Related]
34. Immunoneutralization of glycoprotein Ibalpha attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo.
Katayama T; Ikeda Y; Handa M; Tamatani T; Sakamoto S; Ito M; Ishimura Y; Suematsu M
Circ Res; 2000 May; 86(10):1031-7. PubMed ID: 10827132
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Molecular Interaction between Platelet Glycoprotein Ibα and von Willebrand Factor using Molecular Dynamics Simulations.
Shiozaki S; Takagi S; Goto S
J Atheroscler Thromb; 2016; 23(4):455-64. PubMed ID: 26581184
[TBL] [Abstract][Full Text] [Related]
37. Quantitative Characterization of Shear-Induced Platelet Receptor Shedding: Glycoprotein Ibα, Glycoprotein VI, and Glycoprotein IIb/IIIa.
Chen Z; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
ASAIO J; 2018; 64(6):773-778. PubMed ID: 29117043
[TBL] [Abstract][Full Text] [Related]
38. Platelet physiology and thrombosis.
Andrews RK; Berndt MC
Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
[TBL] [Abstract][Full Text] [Related]
39. The phytotoxin fusicoccin promotes platelet aggregation via 14-3-3-glycoprotein Ib-IX-V interaction.
Camoni L; Di Lucente C; Visconti S; Aducci P
Biochem J; 2011 Jun; 436(2):429-36. PubMed ID: 21395556
[TBL] [Abstract][Full Text] [Related]
40. Targeting of liposomes carrying recombinant fragments of platelet membrane glycoprotein Ibalpha to immobilized von Willebrand factor under flow conditions.
Nishiya T; Murata M; Handa M; Ikeda Y
Biochem Biophys Res Commun; 2000 Apr; 270(3):755-60. PubMed ID: 10772897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
